Kurt Schrader: “I think a lot of what goes forward in the climate change bill is all about confidence.”

The BIOSIM Act is a commonsense approach to increase the utilization of biosimilars in this country.

The success that WRDA has had during these divided times is a testament to the committee's willingness to work across the aisle.

We reduce the out-of-pocket expense for seniors to $2,000 a year that they can pay over the course of the year to make it as affordable as possible to them.

That prescription drug bill is an excellent, excellent balance between H.R. 3 and what others would perhaps like to do.